← back to search

Alexander Engel

Royal North Shore Hospital · AU
Area of research
Surgery · Oncology
Research interest
Research interests include Colorectal Cancer Surgical Treatments, Gastric Cancer Management and Outcomes, Gastrointestinal disorders and treatments, and Anorectal Disease Treatments and Outcomes.
h-index
39
citations
6,186
works
200
NIH funding
primary concept
email

Recent publications

Mutational Analysis of Early, Low-Grade Bowel Polyps Defines a Subgroup with Concurrent, High-Risk Oncogenic Drivers Independent of Polyp Size
Cancer Research Communications 2025cited by 0position: contributordoi
Supplementary Table S3 from Mutational Analysis of Early, Low-Grade Bowel Polyps Defines a Subgroup with Concurrent, High-Risk Oncogenic Drivers Independent of Polyp Size
2025cited by 0position: contributordoi
Supplementary Table S7 from Mutational Analysis of Early, Low-Grade Bowel Polyps Defines a Subgroup with Concurrent, High-Risk Oncogenic Drivers Independent of Polyp Size
2025cited by 0position: contributordoi
Supplementary Table S1 from Mutational Analysis of Early, Low-Grade Bowel Polyps Defines a Subgroup with Concurrent, High-Risk Oncogenic Drivers Independent of Polyp Size
2025cited by 0position: contributordoi
Supplementary Table S6 from Mutational Analysis of Early, Low-Grade Bowel Polyps Defines a Subgroup with Concurrent, High-Risk Oncogenic Drivers Independent of Polyp Size
2025cited by 0position: contributordoi
Table 1 from Mutational Analysis of Early, Low-Grade Bowel Polyps Defines a Subgroup with Concurrent, High-Risk Oncogenic Drivers Independent of Polyp Size
2025cited by 0position: contributordoi
Supplementary Figure S11 from Mutational Analysis of Early, Low-Grade Bowel Polyps Defines a Subgroup with Concurrent, High-Risk Oncogenic Drivers Independent of Polyp Size
2025cited by 0position: contributordoi
Supplementary Figure S5 from Mutational Analysis of Early, Low-Grade Bowel Polyps Defines a Subgroup with Concurrent, High-Risk Oncogenic Drivers Independent of Polyp Size
2025cited by 0position: contributordoi
Figure 3 from Mutational Analysis of Early, Low-Grade Bowel Polyps Defines a Subgroup with Concurrent, High-Risk Oncogenic Drivers Independent of Polyp Size
2025cited by 0position: contributordoi
Supplementary Figure S6 from Mutational Analysis of Early, Low-Grade Bowel Polyps Defines a Subgroup with Concurrent, High-Risk Oncogenic Drivers Independent of Polyp Size
2025cited by 0position: contributordoi
Supplementary Figure S10 from Mutational Analysis of Early, Low-Grade Bowel Polyps Defines a Subgroup with Concurrent, High-Risk Oncogenic Drivers Independent of Polyp Size
2025cited by 0position: contributordoi
Data from Mutational Analysis of Early, Low-Grade Bowel Polyps Defines a Subgroup with Concurrent, High-Risk Oncogenic Drivers Independent of Polyp Size
2025cited by 0position: contributordoi
Supplementary Table S4 from Mutational Analysis of Early, Low-Grade Bowel Polyps Defines a Subgroup with Concurrent, High-Risk Oncogenic Drivers Independent of Polyp Size
2025cited by 0position: contributordoi
Supplementary Figure S7 from Mutational Analysis of Early, Low-Grade Bowel Polyps Defines a Subgroup with Concurrent, High-Risk Oncogenic Drivers Independent of Polyp Size
2025cited by 0position: contributordoi
Supplementary Figure S3 from Mutational Analysis of Early, Low-Grade Bowel Polyps Defines a Subgroup with Concurrent, High-Risk Oncogenic Drivers Independent of Polyp Size
2025cited by 0position: contributordoi
Supplementary Figure S9 from Mutational Analysis of Early, Low-Grade Bowel Polyps Defines a Subgroup with Concurrent, High-Risk Oncogenic Drivers Independent of Polyp Size
2025cited by 0position: contributordoi
Supplementary Figure S4 from Mutational Analysis of Early, Low-Grade Bowel Polyps Defines a Subgroup with Concurrent, High-Risk Oncogenic Drivers Independent of Polyp Size
2025cited by 0position: contributordoi
Supplementary Figure S2 from Mutational Analysis of Early, Low-Grade Bowel Polyps Defines a Subgroup with Concurrent, High-Risk Oncogenic Drivers Independent of Polyp Size
2025cited by 0position: contributordoi
Supplementary Table S2 from Mutational Analysis of Early, Low-Grade Bowel Polyps Defines a Subgroup with Concurrent, High-Risk Oncogenic Drivers Independent of Polyp Size
2025cited by 0position: contributordoi
Supplementary Table S8 from Mutational Analysis of Early, Low-Grade Bowel Polyps Defines a Subgroup with Concurrent, High-Risk Oncogenic Drivers Independent of Polyp Size
2025cited by 0position: contributordoi
Supplementary Table S5 from Mutational Analysis of Early, Low-Grade Bowel Polyps Defines a Subgroup with Concurrent, High-Risk Oncogenic Drivers Independent of Polyp Size
2025cited by 0position: contributordoi
Supplementary Figure S8 from Mutational Analysis of Early, Low-Grade Bowel Polyps Defines a Subgroup with Concurrent, High-Risk Oncogenic Drivers Independent of Polyp Size
2025cited by 0position: contributordoi
Figure 1 from Mutational Analysis of Early, Low-Grade Bowel Polyps Defines a Subgroup with Concurrent, High-Risk Oncogenic Drivers Independent of Polyp Size
2025cited by 0position: contributordoi
Supplementary Figure S1 from Mutational Analysis of Early, Low-Grade Bowel Polyps Defines a Subgroup with Concurrent, High-Risk Oncogenic Drivers Independent of Polyp Size
2025cited by 0position: contributordoi
Figure 4 from Mutational Analysis of Early, Low-Grade Bowel Polyps Defines a Subgroup with Concurrent, High-Risk Oncogenic Drivers Independent of Polyp Size
2025cited by 0position: contributordoi
Figure 2 from Mutational Analysis of Early, Low-Grade Bowel Polyps Defines a Subgroup with Concurrent, High-Risk Oncogenic Drivers Independent of Polyp Size
2025cited by 0position: contributordoi
Estimated incidence of disruptions to event-free survival from non-metastatic cancers in New South Wales, Australia - a population-wide epidemiological study of linked cancer registry and treatment data
Frontiers in Oncology 2024cited by 1position: middledoi
Mucosal Microbiome in Patients with Early Bowel Polyps: Inferences from Short-Read and Long-Read 16S rRNA Sequencing
Cancers 2023cited by 33position: middledoi
Quantification of short-chain fatty acids in human stool samples by LC-MS/MS following derivatization with aniline analogues
Journal of Chromatography B 2023cited by 20position: middledoi
Mucosal Microbiome in Patients with Early Bowel Polyps: Inferences from Short-Read and Long-Read 16S rRNA Sequencing
Cancers 2023cited by 9position: contributordoi

Grants

No grants ingested yet.

Frequent collaborators

· 28 papers (2022–2025) · 28 papers (2022–2025)Mark Molloy · UNSW Sydney28 papers (2022–2025)Shila Ghazanfar · New York Genome Center26 papers (2025–2025)Benita C.Y. Tse · University of Sydney26 papers (2025–2025)Pratibha Panwar · Jaypee University of Information Technology26 papers (2025–2025)Chahaya Gauci · Monash University26 papers (2025–2025)Zoe Welham · 26 papers (2025–2025)Wei Deng · UNSW Sydney3 papers (2018–2021)Anna Guller · UNSW Sydney2 papers (2018–2020)Sandhya Clement · UNSW Sydney2 papers (2018–2020)Ewa M. Goldys · UNSW Sydney2 papers (2018–2020)Mark P. Molloy · The University of Sydney2 papers (2023–2023)Stephen Clarke · Carnegie Mellon University2 papers (2017–2023)Rui Sang · UNSW Sydney1 papers (2021–2021)Justin Evans · Royal North Shore Hospital1 papers (2015–2015)T. Barnes · Atrium Health Wake Forest Baptist1 papers (2017–2017)Elizabeth J. Bernard · Royal North Shore Hospital1 papers (2017–2017)Miguel Castaneda · University of Sydney1 papers (2023–2023)David LH Chan · University of Sydney1 papers (2017–2017)